Sign in to view content

Subretinal Delivery of RGX-314 for Neovascular AMD: End of Study Phase I/IIa Results

Lejla Vajzovic, MD, FASRS

Video
Published 2021

Related

Early Fluid-Free Status & Long-Term BCVA Outcomes With Anti-VEGF Treatment in nAMD: Post Hoc Analysis of Pooled Data From HAWK & HARRIER Studies
Chirag D. Jhaveri, MD, FASRS
On Demand Cases, Courses, and Papers
2020
Episode 204: Journal Club Featuring AMD Cost Analysis, DME Real-World Trends, PVDs and Retinal Breaks
Jayanth Sridhar, MD
Member Podcasts
2019
Defining and Addressing Wet AMD Non-responders
Rishi P. Singh, MD
Updates from the Field
2019

Category: AMD-Neovascular

See more